Clinical trial · Observational
Blood Flow MRI for Monitoring Brain Tumors
Blood Flow MRI for Monitoring of Glioma Angiogenesis
NCT01538264CI-TRIAL-00076538GliomaunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators are studying the use of an advanced magnetic resonance imaging (MRI) technique for measuring blood flow into brain tumors. This technique does not use radioactive tracers, and it can provide high quality images that can be obtained in a standard MRI scanner.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Tumors | Brain Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * diagnosed with or are suspected of having a glioma Exclusion Criteria: * contraindications to MRI which may include the following 1. Pacemaker 2. MRI incompatible metal implant 3. Recently implanted vascular clip 4. History of claustrophobia 5. Metal fragment within the eye Subjects who have received nonstandard therapy may be excluded if the therapy might alter tumor blood flow or other imaging characteristic.
References
Publications (0)
Data not yet available
No reference posted for this study.